Literature DB >> 23734638

Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients.

Tetsuo Takanashi1, Masayuki Matsuda, Masahide Yazaki, Hideshi Yamazaki, Masashi Nawata, Yoshiki Katagiri, Shu-Ichi Ikeda.   

Abstract

OBJECTIVE: To investigate histological features of deposited amyloid in the synovial tissue and its clinical significance in knee joint osteoarthritis (OA) patients.
METHODS: We prospectively enrolled 232 consecutive patients who underwent arthroplasty or total replacement of the knee joint for treatment of OA. Congo red staining and immunohistochemistry were performed in the synovial tissue obtained at surgery. When transthyretin (TTR)-derived amyloid was positive, we analyzed all 4 exons of the TTR gene using the direct DNA sequencing method in order to detect mutations.
RESULTS: We analyzed 322 specimens in this study. Twenty-six specimens (8.1%) obtained from 21 patients (5 men and 16 women; mean, 79.0 ± 4.6 years) showed deposition of amyloid, which was positively stained with the anti-TTR antibody. Eighteen patients showed inhomogeneous accumulations of amyloid in the loose connective tissue under the synovial epithelia sometimes with nodule formation, while in the remaining three, small vessels in the adipose tissue were involved. Medical records of these patients revealed nothing remarkable in the clinical course, laboratory data or macroscopic intraarticular findings at surgery. No mutations were detectable in the TTR gene analysis.
CONCLUSION: Wild-type TTR-derived amyloid may affect the synovial tissue as a result of long-term mechanical stress or as a part of senile systemic amyloidosis in approximately 8% of knee joint OA patients. No obvious clinical significance was found in synovial deposition of amyloid.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23734638     DOI: 10.3109/13506129.2013.803190

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  7 in total

1.  Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.

Authors:  Yukio Akasaki; Natàlia Reixach; Tokio Matsuzaki; Oscar Alvarez-Garcia; Merissa Olmer; Yukihide Iwamoto; Joel N Buxbaum; Martin K Lotz
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

2.  Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

Authors:  Fabian Aus dem Siepen; Selina Hein; Sofie Prestel; Christian Baumgärtner; Stefan Schönland; Ute Hegenbart; Christoph Röcken; Hugo A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2019-04-05       Impact factor: 5.460

3.  Autoimmune response to transthyretin in juvenile idiopathic arthritis.

Authors:  Cristina C Clement; Halima Moncrieffe; Aditi Lele; Ginger Janow; Aniuska Becerra; Francesco Bauli; Fawzy A Saad; Giorgio Perino; Cristina Montagna; Neil Cobelli; John Hardin; Lawrence J Stern; Norman Ilowite; Steven A Porcelli; Laura Santambrogio
Journal:  JCI Insight       Date:  2016-02-25

4.  Amyloid arthropathy in smoldering myeloma: Do not take it lightly.

Authors:  Eli Muchtar; Rebecca L King; Ellen D McPhail; Matthew P Thorpe; Wilson Gonsalves; Floranne Ernste; Martha Grogan; Angela Dispenzieri; Morie A Gertz
Journal:  Leuk Res Rep       Date:  2021-04-24

5.  Transthyretin deposition promotes progression of osteoarthritis.

Authors:  Tokio Matsuzaki; Yukio Akasaki; Merissa Olmer; Oscar Alvarez-Garcia; Natalia Reixach; Joel N Buxbaum; Martin K Lotz
Journal:  Aging Cell       Date:  2017-09-22       Impact factor: 9.304

6.  Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery.

Authors:  Austin E Wininger; Brian M Phelps; Jessica T Le; Joshua D Harris; Barry H Trachtenberg; Shari R Liberman
Journal:  BMC Musculoskelet Disord       Date:  2021-01-08       Impact factor: 2.362

7.  Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.

Authors:  Lia Millucci; Lorenzo Ghezzi; Eugenio Paccagnini; Giovanna Giorgetti; Cecilia Viti; Daniela Braconi; Marcella Laschi; Michela Geminiani; Patrizia Soldani; Pietro Lupetti; Maurizio Orlandini; Chiara Benvenuti; Federico Perfetto; Adriano Spreafico; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.